Neurocognitive assessment and pharmacotherapy towards prevention of schizophrenia: What can we learn from first episode psychosis?

Tomiki Sumiyoshi*, Yasuhiro Kawasaki, Michio Suzuki, Yuko Higuchi, Shimako Nishiyama, Masayoshi Kurachi

*この論文の責任著者

研究成果: ジャーナルへの寄稿総説査読

4 被引用数 (Scopus)

抄録

Research into first episode psychosis (FEP) is a growing field in psychiatry. In this paper, the authors provide an overview of neurocognitive findings and therapeutic approaches indicated for patients with FEP. Focus will be placed on evidence from neuropsychological assessment and brain imaging of electrophysiological activities, as well as the ability of some psychotropic drugs, such as second generation antipsychotics, to improve functional outcome. Efforts to identify biological signals characteristic of FEP are expected to facilitate early intervention into schizophrenia and related disorders.

本文言語英語
ページ(範囲)57-64
ページ数8
ジャーナルClinical Psychopharmacology and Neuroscience
6
2
出版ステータス出版済み - 2008/08

ASJC Scopus 主題領域

  • 精神医学および精神衛生
  • 行動神経科学
  • 薬理学(医学)

フィンガープリント

「Neurocognitive assessment and pharmacotherapy towards prevention of schizophrenia: What can we learn from first episode psychosis?」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル